IGC Pharma
32 hedge funds and large institutions have $7.9M invested in IGC Pharma in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $7.9M → $7.9M (+$4K)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Holders
32
Holding in Top 10
–
Calls
$823K
Puts
$687K
Top Buyers
| 1 | +$599K | |
| 2 | +$443K | |
| 3 | +$205K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$143K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$83K |
Top Sellers
| 1 | -$258K | |
| 2 | -$177K | |
| 3 | -$104K | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
-$98K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$71K |